nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A4—Temozolomide—malignant glioma	0.0777	1	CbGbCtD
Fentanyl—Cyst—Carmustine—malignant glioma	0.00538	0.00737	CcSEcCtD
Fentanyl—Aphasia—Temozolomide—malignant glioma	0.00536	0.00734	CcSEcCtD
Fentanyl—Parosmia—Temozolomide—malignant glioma	0.00536	0.00734	CcSEcCtD
Fentanyl—Tooth disorder—Temozolomide—malignant glioma	0.00536	0.00734	CcSEcCtD
Fentanyl—Hypokinesia—Carmustine—malignant glioma	0.00533	0.00729	CcSEcCtD
Fentanyl—Paranoia—Carmustine—malignant glioma	0.00527	0.00722	CcSEcCtD
Fentanyl—Burning sensation—Carmustine—malignant glioma	0.00517	0.00709	CcSEcCtD
Fentanyl—Myopathy—Temozolomide—malignant glioma	0.00495	0.00678	CcSEcCtD
Fentanyl—Lung disorder—Temozolomide—malignant glioma	0.00491	0.00672	CcSEcCtD
Fentanyl—Influenza-like symptoms—Temozolomide—malignant glioma	0.00486	0.00666	CcSEcCtD
Fentanyl—Stupor—Carmustine—malignant glioma	0.00482	0.00659	CcSEcCtD
Fentanyl—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00469	0.00643	CcSEcCtD
Fentanyl—Herpes zoster—Temozolomide—malignant glioma	0.00461	0.00632	CcSEcCtD
Fentanyl—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00461	0.00632	CcSEcCtD
Fentanyl—Abscess—Carmustine—malignant glioma	0.00454	0.00622	CcSEcCtD
Fentanyl—Memory impairment—Temozolomide—malignant glioma	0.00443	0.00606	CcSEcCtD
Fentanyl—Injection site pain—Carmustine—malignant glioma	0.0044	0.00603	CcSEcCtD
Fentanyl—Rigors—Temozolomide—malignant glioma	0.00426	0.00583	CcSEcCtD
Fentanyl—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00422	0.00578	CcSEcCtD
Fentanyl—Endocrine disorder—Temozolomide—malignant glioma	0.00419	0.00574	CcSEcCtD
Fentanyl—Speech disorder—Carmustine—malignant glioma	0.00418	0.00572	CcSEcCtD
Fentanyl—Accidental injury—Carmustine—malignant glioma	0.00406	0.00556	CcSEcCtD
Fentanyl—Speech disorder—Temozolomide—malignant glioma	0.00404	0.00553	CcSEcCtD
Fentanyl—Disturbance in attention—Temozolomide—malignant glioma	0.00401	0.00549	CcSEcCtD
Fentanyl—Breast pain—Temozolomide—malignant glioma	0.00398	0.00545	CcSEcCtD
Fentanyl—Thinking abnormal—Carmustine—malignant glioma	0.00393	0.00538	CcSEcCtD
Fentanyl—Drug interaction—Carmustine—malignant glioma	0.00388	0.00531	CcSEcCtD
Fentanyl—Viral infection—Temozolomide—malignant glioma	0.00385	0.00527	CcSEcCtD
Fentanyl—Gait disturbance—Carmustine—malignant glioma	0.00368	0.00504	CcSEcCtD
Fentanyl—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00367	0.00503	CcSEcCtD
Fentanyl—Coordination abnormal—Carmustine—malignant glioma	0.00366	0.00501	CcSEcCtD
Fentanyl—Neck pain—Carmustine—malignant glioma	0.00364	0.00498	CcSEcCtD
Fentanyl—Pulmonary embolism—Carmustine—malignant glioma	0.0036	0.00492	CcSEcCtD
Fentanyl—Gait disturbance—Temozolomide—malignant glioma	0.00356	0.00487	CcSEcCtD
Fentanyl—Coordination abnormal—Temozolomide—malignant glioma	0.00354	0.00485	CcSEcCtD
Fentanyl—Respiratory failure—Temozolomide—malignant glioma	0.00354	0.00485	CcSEcCtD
Fentanyl—Musculoskeletal pain—Temozolomide—malignant glioma	0.00352	0.00482	CcSEcCtD
Fentanyl—Vaginal inflammation—Temozolomide—malignant glioma	0.00347	0.00476	CcSEcCtD
Fentanyl—Pulmonary embolism—Temozolomide—malignant glioma	0.00347	0.00476	CcSEcCtD
Fentanyl—Depressed level of consciousness—Carmustine—malignant glioma	0.00347	0.00475	CcSEcCtD
Fentanyl—Urinary incontinence—Carmustine—malignant glioma	0.00347	0.00475	CcSEcCtD
Fentanyl—Candida infection—Carmustine—malignant glioma	0.00343	0.0047	CcSEcCtD
Fentanyl—Neuropathy—Carmustine—malignant glioma	0.00338	0.00462	CcSEcCtD
Fentanyl—Influenza like illness—Temozolomide—malignant glioma	0.00337	0.00462	CcSEcCtD
Fentanyl—Urinary incontinence—Temozolomide—malignant glioma	0.00335	0.00459	CcSEcCtD
Fentanyl—Depressed level of consciousness—Temozolomide—malignant glioma	0.00335	0.00459	CcSEcCtD
Fentanyl—Candida infection—Temozolomide—malignant glioma	0.00332	0.00454	CcSEcCtD
Fentanyl—Benzphetamine—POR—malignant glioma	0.00331	0.15	CrCbGaD
Fentanyl—Coma—Carmustine—malignant glioma	0.00329	0.0045	CcSEcCtD
Fentanyl—Vaginal infection—Temozolomide—malignant glioma	0.00328	0.00449	CcSEcCtD
Fentanyl—Neuropathy—Temozolomide—malignant glioma	0.00326	0.00447	CcSEcCtD
Fentanyl—Neoplasm—Carmustine—malignant glioma	0.00325	0.00445	CcSEcCtD
Fentanyl—Dry eye—Temozolomide—malignant glioma	0.00321	0.00439	CcSEcCtD
Fentanyl—OPRM1—telencephalic ventricle—malignant glioma	0.00318	0.248	CbGeAlD
Fentanyl—Neoplasm—Temozolomide—malignant glioma	0.00314	0.0043	CcSEcCtD
Fentanyl—Abnormal vision—Carmustine—malignant glioma	0.00314	0.00429	CcSEcCtD
Fentanyl—Sepsis—Carmustine—malignant glioma	0.00312	0.00427	CcSEcCtD
Fentanyl—Mental disability—Carmustine—malignant glioma	0.00312	0.00427	CcSEcCtD
Fentanyl—Abnormal vision—Temozolomide—malignant glioma	0.00303	0.00415	CcSEcCtD
Fentanyl—Mental disability—Temozolomide—malignant glioma	0.00301	0.00413	CcSEcCtD
Fentanyl—Thrombophlebitis—Carmustine—malignant glioma	0.00301	0.00413	CcSEcCtD
Fentanyl—Swelling—Carmustine—malignant glioma	0.00296	0.00405	CcSEcCtD
Fentanyl—Ear pain—Temozolomide—malignant glioma	0.00296	0.00405	CcSEcCtD
Fentanyl—Thrombophlebitis—Temozolomide—malignant glioma	0.00291	0.00399	CcSEcCtD
Fentanyl—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0029	0.00397	CcSEcCtD
Fentanyl—Gastroenteritis—Temozolomide—malignant glioma	0.00285	0.0039	CcSEcCtD
Fentanyl—Injury—Carmustine—malignant glioma	0.00284	0.00389	CcSEcCtD
Fentanyl—Amnesia—Carmustine—malignant glioma	0.00278	0.0038	CcSEcCtD
Fentanyl—Nasal congestion—Temozolomide—malignant glioma	0.00277	0.00379	CcSEcCtD
Fentanyl—Hot flush—Temozolomide—malignant glioma	0.0027	0.00369	CcSEcCtD
Fentanyl—Amnesia—Temozolomide—malignant glioma	0.00268	0.00368	CcSEcCtD
Fentanyl—Menopausal symptoms—Temozolomide—malignant glioma	0.00267	0.00366	CcSEcCtD
Fentanyl—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00267	0.00366	CcSEcCtD
Fentanyl—Thirst—Temozolomide—malignant glioma	0.00265	0.00363	CcSEcCtD
Fentanyl—Hyponatraemia—Carmustine—malignant glioma	0.00262	0.00359	CcSEcCtD
Fentanyl—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00261	0.00357	CcSEcCtD
Fentanyl—Face oedema—Carmustine—malignant glioma	0.00252	0.00345	CcSEcCtD
Fentanyl—Affect lability—Temozolomide—malignant glioma	0.00248	0.0034	CcSEcCtD
Fentanyl—Face oedema—Temozolomide—malignant glioma	0.00243	0.00333	CcSEcCtD
Fentanyl—Mood swings—Temozolomide—malignant glioma	0.00239	0.00327	CcSEcCtD
Fentanyl—Hypokalaemia—Carmustine—malignant glioma	0.00237	0.00325	CcSEcCtD
Fentanyl—Dehydration—Temozolomide—malignant glioma	0.00235	0.00321	CcSEcCtD
Fentanyl—Trimethaphan—BCHE—malignant glioma	0.00233	0.106	CrCbGaD
Fentanyl—Muscular weakness—Carmustine—malignant glioma	0.0023	0.00315	CcSEcCtD
Fentanyl—Hypokalaemia—Temozolomide—malignant glioma	0.0023	0.00314	CcSEcCtD
Fentanyl—Breast disorder—Temozolomide—malignant glioma	0.00228	0.00312	CcSEcCtD
Fentanyl—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00227	0.00311	CcSEcCtD
Fentanyl—Dysphagia—Carmustine—malignant glioma	0.00226	0.00309	CcSEcCtD
Fentanyl—Muscular weakness—Temozolomide—malignant glioma	0.00222	0.00305	CcSEcCtD
Fentanyl—Abdominal distension—Temozolomide—malignant glioma	0.00219	0.00301	CcSEcCtD
Fentanyl—Dysphagia—Temozolomide—malignant glioma	0.00218	0.00299	CcSEcCtD
Fentanyl—Pancytopenia—Carmustine—malignant glioma	0.00214	0.00293	CcSEcCtD
Fentanyl—Sweating increased—Temozolomide—malignant glioma	0.00212	0.00291	CcSEcCtD
Fentanyl—Neutropenia—Carmustine—malignant glioma	0.00211	0.00289	CcSEcCtD
Fentanyl—Bronchitis—Temozolomide—malignant glioma	0.0021	0.00287	CcSEcCtD
Fentanyl—Pancytopenia—Temozolomide—malignant glioma	0.00207	0.00283	CcSEcCtD
Fentanyl—Diphenylpyraline—SLC6A3—malignant glioma	0.00205	0.0928	CrCbGaD
Fentanyl—Dysuria—Temozolomide—malignant glioma	0.00204	0.00279	CcSEcCtD
Fentanyl—Neutropenia—Temozolomide—malignant glioma	0.00204	0.00279	CcSEcCtD
Fentanyl—Hyperglycaemia—Carmustine—malignant glioma	0.00203	0.00279	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00203	0.00277	CcSEcCtD
Fentanyl—Pneumonia—Carmustine—malignant glioma	0.00202	0.00277	CcSEcCtD
Fentanyl—Pollakiuria—Temozolomide—malignant glioma	0.00201	0.00276	CcSEcCtD
Fentanyl—Erectile dysfunction—Temozolomide—malignant glioma	0.00201	0.00275	CcSEcCtD
Fentanyl—Depression—Carmustine—malignant glioma	0.00201	0.00275	CcSEcCtD
Fentanyl—Weight increased—Temozolomide—malignant glioma	0.00198	0.00272	CcSEcCtD
Fentanyl—Renal failure—Carmustine—malignant glioma	0.00198	0.00271	CcSEcCtD
Fentanyl—Weight decreased—Temozolomide—malignant glioma	0.00197	0.0027	CcSEcCtD
Fentanyl—Neuropathy peripheral—Carmustine—malignant glioma	0.00197	0.0027	CcSEcCtD
Fentanyl—Hyperglycaemia—Temozolomide—malignant glioma	0.00197	0.00269	CcSEcCtD
Fentanyl—Stomatitis—Carmustine—malignant glioma	0.00196	0.00268	CcSEcCtD
Fentanyl—Urinary tract infection—Carmustine—malignant glioma	0.00195	0.00268	CcSEcCtD
Fentanyl—Pneumonia—Temozolomide—malignant glioma	0.00195	0.00268	CcSEcCtD
Fentanyl—Infestation NOS—Temozolomide—malignant glioma	0.00194	0.00266	CcSEcCtD
Fentanyl—Infestation—Temozolomide—malignant glioma	0.00194	0.00266	CcSEcCtD
Fentanyl—Depression—Temozolomide—malignant glioma	0.00194	0.00265	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00193	0.00264	CcSEcCtD
Fentanyl—Neuropathy peripheral—Temozolomide—malignant glioma	0.00191	0.00261	CcSEcCtD
Fentanyl—Stomatitis—Temozolomide—malignant glioma	0.00189	0.00259	CcSEcCtD
Fentanyl—Urinary tract infection—Temozolomide—malignant glioma	0.00189	0.00259	CcSEcCtD
Fentanyl—Hepatobiliary disease—Temozolomide—malignant glioma	0.00184	0.00252	CcSEcCtD
Fentanyl—Sinusitis—Temozolomide—malignant glioma	0.00182	0.0025	CcSEcCtD
Fentanyl—Haemoglobin—Carmustine—malignant glioma	0.00181	0.00248	CcSEcCtD
Fentanyl—Haemorrhage—Carmustine—malignant glioma	0.00181	0.00247	CcSEcCtD
Fentanyl—Hypoaesthesia—Carmustine—malignant glioma	0.0018	0.00246	CcSEcCtD
Fentanyl—Hallucination—Carmustine—malignant glioma	0.0018	0.00246	CcSEcCtD
Fentanyl—Oedema peripheral—Carmustine—malignant glioma	0.00178	0.00244	CcSEcCtD
Fentanyl—Connective tissue disorder—Carmustine—malignant glioma	0.00177	0.00243	CcSEcCtD
Fentanyl—Haemoglobin—Temozolomide—malignant glioma	0.00175	0.0024	CcSEcCtD
Fentanyl—Haemorrhage—Temozolomide—malignant glioma	0.00174	0.00239	CcSEcCtD
Fentanyl—Visual impairment—Carmustine—malignant glioma	0.00174	0.00238	CcSEcCtD
Fentanyl—Hypoaesthesia—Temozolomide—malignant glioma	0.00174	0.00238	CcSEcCtD
Fentanyl—Hallucination—Temozolomide—malignant glioma	0.00174	0.00238	CcSEcCtD
Fentanyl—Pharyngitis—Temozolomide—malignant glioma	0.00173	0.00237	CcSEcCtD
Fentanyl—Urinary tract disorder—Temozolomide—malignant glioma	0.00172	0.00236	CcSEcCtD
Fentanyl—Oedema peripheral—Temozolomide—malignant glioma	0.00172	0.00235	CcSEcCtD
Fentanyl—Connective tissue disorder—Temozolomide—malignant glioma	0.00171	0.00235	CcSEcCtD
Fentanyl—Urethral disorder—Temozolomide—malignant glioma	0.00171	0.00234	CcSEcCtD
Fentanyl—Eye disorder—Carmustine—malignant glioma	0.00169	0.00231	CcSEcCtD
Fentanyl—Visual impairment—Temozolomide—malignant glioma	0.00168	0.0023	CcSEcCtD
Fentanyl—Flushing—Carmustine—malignant glioma	0.00168	0.00229	CcSEcCtD
Fentanyl—Erythema multiforme—Temozolomide—malignant glioma	0.00165	0.00226	CcSEcCtD
Fentanyl—Eye disorder—Temozolomide—malignant glioma	0.00163	0.00223	CcSEcCtD
Fentanyl—Tinnitus—Temozolomide—malignant glioma	0.00163	0.00223	CcSEcCtD
Fentanyl—Cardiac disorder—Temozolomide—malignant glioma	0.00162	0.00222	CcSEcCtD
Fentanyl—Flushing—Temozolomide—malignant glioma	0.00162	0.00222	CcSEcCtD
Fentanyl—Arrhythmia—Carmustine—malignant glioma	0.00161	0.00221	CcSEcCtD
Fentanyl—Alopecia—Carmustine—malignant glioma	0.0016	0.00218	CcSEcCtD
Fentanyl—Angiopathy—Temozolomide—malignant glioma	0.00158	0.00217	CcSEcCtD
Fentanyl—Mental disorder—Carmustine—malignant glioma	0.00158	0.00217	CcSEcCtD
Fentanyl—Immune system disorder—Temozolomide—malignant glioma	0.00158	0.00216	CcSEcCtD
Fentanyl—Mediastinal disorder—Temozolomide—malignant glioma	0.00157	0.00215	CcSEcCtD
Fentanyl—Erythema—Carmustine—malignant glioma	0.00157	0.00215	CcSEcCtD
Fentanyl—Malnutrition—Carmustine—malignant glioma	0.00157	0.00215	CcSEcCtD
Fentanyl—Benzatropine—SLC6A3—malignant glioma	0.00157	0.0712	CrCbGaD
Fentanyl—Chills—Temozolomide—malignant glioma	0.00157	0.00214	CcSEcCtD
Fentanyl—Alopecia—Temozolomide—malignant glioma	0.00154	0.00211	CcSEcCtD
Fentanyl—Mental disorder—Temozolomide—malignant glioma	0.00153	0.00209	CcSEcCtD
Fentanyl—Back pain—Carmustine—malignant glioma	0.00152	0.00208	CcSEcCtD
Fentanyl—Erythema—Temozolomide—malignant glioma	0.00152	0.00208	CcSEcCtD
Fentanyl—Malnutrition—Temozolomide—malignant glioma	0.00152	0.00208	CcSEcCtD
Fentanyl—Dysgeusia—Temozolomide—malignant glioma	0.00149	0.00204	CcSEcCtD
Fentanyl—Vision blurred—Carmustine—malignant glioma	0.00148	0.00203	CcSEcCtD
Fentanyl—Tremor—Carmustine—malignant glioma	0.00147	0.00202	CcSEcCtD
Fentanyl—Back pain—Temozolomide—malignant glioma	0.00147	0.00201	CcSEcCtD
Fentanyl—Anaemia—Carmustine—malignant glioma	0.00145	0.00199	CcSEcCtD
Fentanyl—Agitation—Carmustine—malignant glioma	0.00144	0.00198	CcSEcCtD
Fentanyl—Vision blurred—Temozolomide—malignant glioma	0.00143	0.00196	CcSEcCtD
Fentanyl—Tremor—Temozolomide—malignant glioma	0.00142	0.00195	CcSEcCtD
Fentanyl—Ill-defined disorder—Temozolomide—malignant glioma	0.00141	0.00193	CcSEcCtD
Fentanyl—Leukopenia—Carmustine—malignant glioma	0.00141	0.00193	CcSEcCtD
Fentanyl—Anaemia—Temozolomide—malignant glioma	0.0014	0.00192	CcSEcCtD
Fentanyl—Agitation—Temozolomide—malignant glioma	0.0014	0.00191	CcSEcCtD
Fentanyl—Malaise—Temozolomide—malignant glioma	0.00137	0.00188	CcSEcCtD
Fentanyl—Vertigo—Temozolomide—malignant glioma	0.00136	0.00187	CcSEcCtD
Fentanyl—Modafinil—CYP2B6—malignant glioma	0.00136	0.0618	CrCbGaD
Fentanyl—Convulsion—Carmustine—malignant glioma	0.00136	0.00186	CcSEcCtD
Fentanyl—Leukopenia—Temozolomide—malignant glioma	0.00136	0.00186	CcSEcCtD
Fentanyl—Hypertension—Carmustine—malignant glioma	0.00136	0.00186	CcSEcCtD
Fentanyl—Palpitations—Temozolomide—malignant glioma	0.00134	0.00184	CcSEcCtD
Fentanyl—Myalgia—Carmustine—malignant glioma	0.00134	0.00183	CcSEcCtD
Fentanyl—Chest pain—Carmustine—malignant glioma	0.00134	0.00183	CcSEcCtD
Fentanyl—Anxiety—Carmustine—malignant glioma	0.00133	0.00183	CcSEcCtD
Fentanyl—Cough—Temozolomide—malignant glioma	0.00133	0.00181	CcSEcCtD
Fentanyl—Convulsion—Temozolomide—malignant glioma	0.00132	0.0018	CcSEcCtD
Fentanyl—Hypertension—Temozolomide—malignant glioma	0.00131	0.0018	CcSEcCtD
Fentanyl—Confusional state—Carmustine—malignant glioma	0.00129	0.00177	CcSEcCtD
Fentanyl—Arthralgia—Temozolomide—malignant glioma	0.00129	0.00177	CcSEcCtD
Fentanyl—Myalgia—Temozolomide—malignant glioma	0.00129	0.00177	CcSEcCtD
Fentanyl—Anxiety—Temozolomide—malignant glioma	0.00129	0.00176	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00128	0.00176	CcSEcCtD
Fentanyl—Loperamide—CYP2B6—malignant glioma	0.00128	0.0583	CrCbGaD
Fentanyl—Oedema—Carmustine—malignant glioma	0.00128	0.00176	CcSEcCtD
Fentanyl—Discomfort—Temozolomide—malignant glioma	0.00128	0.00175	CcSEcCtD
Fentanyl—Diphenhydramine—CYP2C18—malignant glioma	0.00128	0.0579	CrCbGaD
Fentanyl—Infection—Carmustine—malignant glioma	0.00127	0.00175	CcSEcCtD
Fentanyl—Dry mouth—Temozolomide—malignant glioma	0.00126	0.00173	CcSEcCtD
Fentanyl—Thrombocytopenia—Carmustine—malignant glioma	0.00126	0.00172	CcSEcCtD
Fentanyl—Tachycardia—Carmustine—malignant glioma	0.00125	0.00171	CcSEcCtD
Fentanyl—Confusional state—Temozolomide—malignant glioma	0.00125	0.00171	CcSEcCtD
Fentanyl—Anaphylactic shock—Temozolomide—malignant glioma	0.00124	0.0017	CcSEcCtD
Fentanyl—Oedema—Temozolomide—malignant glioma	0.00124	0.0017	CcSEcCtD
Fentanyl—Infection—Temozolomide—malignant glioma	0.00123	0.00169	CcSEcCtD
Fentanyl—Methadone—CYP2C18—malignant glioma	0.00123	0.0559	CrCbGaD
Fentanyl—Anorexia—Carmustine—malignant glioma	0.00122	0.00167	CcSEcCtD
Fentanyl—Nervous system disorder—Temozolomide—malignant glioma	0.00122	0.00166	CcSEcCtD
Fentanyl—Thrombocytopenia—Temozolomide—malignant glioma	0.00121	0.00166	CcSEcCtD
Fentanyl—Skin disorder—Temozolomide—malignant glioma	0.0012	0.00165	CcSEcCtD
Fentanyl—Hypotension—Carmustine—malignant glioma	0.0012	0.00164	CcSEcCtD
Fentanyl—Hyperhidrosis—Temozolomide—malignant glioma	0.0012	0.00164	CcSEcCtD
Fentanyl—Anorexia—Temozolomide—malignant glioma	0.00118	0.00162	CcSEcCtD
Fentanyl—Benzphetamine—CYP2B6—malignant glioma	0.00118	0.0536	CrCbGaD
Fentanyl—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00117	0.0016	CcSEcCtD
Fentanyl—Modafinil—SLC6A3—malignant glioma	0.00116	0.0527	CrCbGaD
Fentanyl—Insomnia—Carmustine—malignant glioma	0.00116	0.00159	CcSEcCtD
Fentanyl—Paraesthesia—Carmustine—malignant glioma	0.00115	0.00158	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS1—malignant glioma	0.00114	0.0519	CrCbGaD
Fentanyl—Dyspnoea—Carmustine—malignant glioma	0.00114	0.00157	CcSEcCtD
Fentanyl—Somnolence—Carmustine—malignant glioma	0.00114	0.00156	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00113	0.00155	CcSEcCtD
Fentanyl—Insomnia—Temozolomide—malignant glioma	0.00112	0.00154	CcSEcCtD
Fentanyl—OPRD1—telencephalon—malignant glioma	0.00112	0.0874	CbGeAlD
Fentanyl—Decreased appetite—Carmustine—malignant glioma	0.00111	0.00153	CcSEcCtD
Fentanyl—Paraesthesia—Temozolomide—malignant glioma	0.00111	0.00152	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Carmustine—malignant glioma	0.00111	0.00152	CcSEcCtD
Fentanyl—Dyspnoea—Temozolomide—malignant glioma	0.00111	0.00151	CcSEcCtD
Fentanyl—Somnolence—Temozolomide—malignant glioma	0.0011	0.00151	CcSEcCtD
Fentanyl—Constipation—Carmustine—malignant glioma	0.0011	0.0015	CcSEcCtD
Fentanyl—Pain—Carmustine—malignant glioma	0.0011	0.0015	CcSEcCtD
Fentanyl—Dyspepsia—Temozolomide—malignant glioma	0.00109	0.00149	CcSEcCtD
Fentanyl—Decreased appetite—Temozolomide—malignant glioma	0.00108	0.00148	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00107	0.00147	CcSEcCtD
Fentanyl—Fatigue—Temozolomide—malignant glioma	0.00107	0.00146	CcSEcCtD
Fentanyl—Constipation—Temozolomide—malignant glioma	0.00106	0.00145	CcSEcCtD
Fentanyl—Pain—Temozolomide—malignant glioma	0.00106	0.00145	CcSEcCtD
Fentanyl—Feeling abnormal—Carmustine—malignant glioma	0.00106	0.00145	CcSEcCtD
Fentanyl—Gastrointestinal pain—Carmustine—malignant glioma	0.00105	0.00144	CcSEcCtD
Fentanyl—Feeling abnormal—Temozolomide—malignant glioma	0.00102	0.0014	CcSEcCtD
Fentanyl—Abdominal pain—Carmustine—malignant glioma	0.00101	0.00139	CcSEcCtD
Fentanyl—Body temperature increased—Carmustine—malignant glioma	0.00101	0.00139	CcSEcCtD
Fentanyl—Gastrointestinal pain—Temozolomide—malignant glioma	0.00101	0.00139	CcSEcCtD
Fentanyl—Benzphetamine—SLC6A3—malignant glioma	0.00101	0.0457	CrCbGaD
Fentanyl—Urticaria—Temozolomide—malignant glioma	0.000985	0.00135	CcSEcCtD
Fentanyl—Body temperature increased—Temozolomide—malignant glioma	0.00098	0.00134	CcSEcCtD
Fentanyl—Abdominal pain—Temozolomide—malignant glioma	0.00098	0.00134	CcSEcCtD
Fentanyl—Diphenhydramine—CYP2B6—malignant glioma	0.000947	0.043	CrCbGaD
Fentanyl—Hypersensitivity—Carmustine—malignant glioma	0.000945	0.00129	CcSEcCtD
Fentanyl—Asthenia—Carmustine—malignant glioma	0.00092	0.00126	CcSEcCtD
Fentanyl—Methadone—CYP2B6—malignant glioma	0.000914	0.0415	CrCbGaD
Fentanyl—Hypersensitivity—Temozolomide—malignant glioma	0.000913	0.00125	CcSEcCtD
Fentanyl—Asthenia—Temozolomide—malignant glioma	0.000889	0.00122	CcSEcCtD
Fentanyl—Diarrhoea—Carmustine—malignant glioma	0.000878	0.0012	CcSEcCtD
Fentanyl—Pruritus—Temozolomide—malignant glioma	0.000877	0.0012	CcSEcCtD
Fentanyl—OPRM1—brainstem—malignant glioma	0.000859	0.0671	CbGeAlD
Fentanyl—Dizziness—Carmustine—malignant glioma	0.000848	0.00116	CcSEcCtD
Fentanyl—Diarrhoea—Temozolomide—malignant glioma	0.000848	0.00116	CcSEcCtD
Fentanyl—Dizziness—Temozolomide—malignant glioma	0.00082	0.00112	CcSEcCtD
Fentanyl—Vomiting—Carmustine—malignant glioma	0.000816	0.00112	CcSEcCtD
Fentanyl—Rash—Carmustine—malignant glioma	0.000809	0.00111	CcSEcCtD
Fentanyl—Dermatitis—Carmustine—malignant glioma	0.000808	0.00111	CcSEcCtD
Fentanyl—Headache—Carmustine—malignant glioma	0.000804	0.0011	CcSEcCtD
Fentanyl—Vomiting—Temozolomide—malignant glioma	0.000788	0.00108	CcSEcCtD
Fentanyl—Rash—Temozolomide—malignant glioma	0.000782	0.00107	CcSEcCtD
Fentanyl—Dermatitis—Temozolomide—malignant glioma	0.000781	0.00107	CcSEcCtD
Fentanyl—Headache—Temozolomide—malignant glioma	0.000777	0.00106	CcSEcCtD
Fentanyl—OPRM1—telencephalon—malignant glioma	0.000762	0.0596	CbGeAlD
Fentanyl—Nausea—Carmustine—malignant glioma	0.000762	0.00104	CcSEcCtD
Fentanyl—Nausea—Temozolomide—malignant glioma	0.000736	0.00101	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS2—malignant glioma	0.000654	0.0297	CrCbGaD
Fentanyl—OPRD1—central nervous system—malignant glioma	0.000635	0.0497	CbGeAlD
Fentanyl—Diphenhydramine—PTGS1—malignant glioma	0.000623	0.0283	CrCbGaD
Fentanyl—OPRK1—central nervous system—malignant glioma	0.000609	0.0476	CbGeAlD
Fentanyl—OPRK1—cerebellum—malignant glioma	0.000595	0.0465	CbGeAlD
Fentanyl—OPRM1—midbrain—malignant glioma	0.000548	0.0428	CbGeAlD
Fentanyl—OPRM1—spinal cord—malignant glioma	0.000534	0.0417	CbGeAlD
Fentanyl—OPRD1—brain—malignant glioma	0.000504	0.0394	CbGeAlD
Fentanyl—OPRK1—brain—malignant glioma	0.000484	0.0378	CbGeAlD
Fentanyl—ABCB1—blood vessel—malignant glioma	0.000453	0.0354	CbGeAlD
Fentanyl—OPRM1—central nervous system—malignant glioma	0.000433	0.0339	CbGeAlD
Fentanyl—OPRM1—brain—malignant glioma	0.000344	0.0269	CbGeAlD
Fentanyl—ABCB1—embryo—malignant glioma	0.00027	0.0211	CbGeAlD
Fentanyl—ABCB1—retina—malignant glioma	0.000239	0.0187	CbGeAlD
Fentanyl—ABCB1—telencephalon—malignant glioma	0.00022	0.0172	CbGeAlD
Fentanyl—CYP3A4—central nervous system—malignant glioma	0.000177	0.0138	CbGeAlD
Fentanyl—ABCB1—medulla oblongata—malignant glioma	0.000173	0.0135	CbGeAlD
Fentanyl—ABCB1—midbrain—malignant glioma	0.000158	0.0123	CbGeAlD
Fentanyl—ABCB1—spinal cord—malignant glioma	0.000154	0.012	CbGeAlD
Fentanyl—ABCB1—central nervous system—malignant glioma	0.000125	0.00977	CbGeAlD
Fentanyl—ABCB1—cerebellum—malignant glioma	0.000122	0.00955	CbGeAlD
Fentanyl—ABCB1—brain—malignant glioma	9.92e-05	0.00775	CbGeAlD
Fentanyl—OPRM1—Signaling by GPCR—F2—malignant glioma	6.53e-05	0.000416	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CD—malignant glioma	6.5e-05	0.000414	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CB—malignant glioma	6.47e-05	0.000411	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PDGFRA—malignant glioma	6.43e-05	0.000409	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—COX8A—malignant glioma	6.35e-05	0.000404	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT2—malignant glioma	6.3e-05	0.000401	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP3—malignant glioma	6.26e-05	0.000398	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CG—malignant glioma	6.25e-05	0.000398	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2B6—malignant glioma	6.25e-05	0.000397	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CB—malignant glioma	6.24e-05	0.000397	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SPP1—malignant glioma	6.24e-05	0.000397	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL8—malignant glioma	6.21e-05	0.000395	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN2B—malignant glioma	6.21e-05	0.000395	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PTPN11—malignant glioma	6.14e-05	0.000391	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.13e-05	0.00039	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH2—malignant glioma	6.1e-05	0.000388	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CD—malignant glioma	6.05e-05	0.000385	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTK2—malignant glioma	6.03e-05	0.000383	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL8—malignant glioma	6e-05	0.000382	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6e-05	0.000381	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KNG1—malignant glioma	5.97e-05	0.00038	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2—malignant glioma	5.94e-05	0.000378	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HES1—malignant glioma	5.92e-05	0.000377	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TERT—malignant glioma	5.92e-05	0.000376	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NCOR1—malignant glioma	5.89e-05	0.000374	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—RAF1—malignant glioma	5.81e-05	0.000369	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTT1—malignant glioma	5.81e-05	0.000369	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PDGFB—malignant glioma	5.77e-05	0.000367	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGFR1—malignant glioma	5.74e-05	0.000365	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2—malignant glioma	5.73e-05	0.000365	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT2—malignant glioma	5.72e-05	0.000364	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—IDH1—malignant glioma	5.72e-05	0.000364	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	5.71e-05	0.000363	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NTRK1—malignant glioma	5.69e-05	0.000362	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CB—malignant glioma	5.67e-05	0.000361	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	5.67e-05	0.00036	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HIF1A—malignant glioma	5.66e-05	0.00036	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PDGFRA—malignant glioma	5.64e-05	0.000359	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTP1—malignant glioma	5.57e-05	0.000354	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SPHK1—malignant glioma	5.53e-05	0.000352	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CD—malignant glioma	5.5e-05	0.00035	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CAV1—malignant glioma	5.47e-05	0.000348	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SPP1—malignant glioma	5.47e-05	0.000348	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL8—malignant glioma	5.45e-05	0.000347	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS1—malignant glioma	5.44e-05	0.000346	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CAT—malignant glioma	5.42e-05	0.000345	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2C18—malignant glioma	5.42e-05	0.000345	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KDR—malignant glioma	5.41e-05	0.000344	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ASMT—malignant glioma	5.4e-05	0.000344	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP3—malignant glioma	5.29e-05	0.000337	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CB—malignant glioma	5.28e-05	0.000336	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN2B—malignant glioma	5.25e-05	0.000334	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—F2—malignant glioma	5.21e-05	0.000331	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FN1—malignant glioma	5.21e-05	0.000331	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2—malignant glioma	5.21e-05	0.000331	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.21e-05	0.000331	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TERT—malignant glioma	5.19e-05	0.00033	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BAD—malignant glioma	5.15e-05	0.000327	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NCOR1—malignant glioma	5.12e-05	0.000325	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH1—malignant glioma	5.1e-05	0.000324	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTK2—malignant glioma	5.09e-05	0.000324	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BCAN—malignant glioma	5.08e-05	0.000323	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	5.07e-05	0.000323	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PDGFB—malignant glioma	5.06e-05	0.000322	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—BCHE—malignant glioma	5.06e-05	0.000322	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGFR1—malignant glioma	5.04e-05	0.00032	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.04e-05	0.00032	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HES1—malignant glioma	5e-05	0.000318	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC5A5—malignant glioma	5e-05	0.000318	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CD80—malignant glioma	4.99e-05	0.000318	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APC—malignant glioma	4.98e-05	0.000317	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CG—malignant glioma	4.98e-05	0.000317	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NCOR1—malignant glioma	4.98e-05	0.000316	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HIF1A—malignant glioma	4.96e-05	0.000316	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGF—malignant glioma	4.93e-05	0.000313	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—RAF1—malignant glioma	4.91e-05	0.000312	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTPN11—malignant glioma	4.9e-05	0.000311	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2—malignant glioma	4.85e-05	0.000308	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CAV1—malignant glioma	4.8e-05	0.000305	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	4.79e-05	0.000305	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	4.76e-05	0.000303	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KDR—malignant glioma	4.74e-05	0.000302	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BRAF—malignant glioma	4.69e-05	0.000298	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SPP1—malignant glioma	4.63e-05	0.000294	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	4.6e-05	0.000293	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FN1—malignant glioma	4.57e-05	0.000291	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—F2—malignant glioma	4.57e-05	0.000291	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT2—malignant glioma	4.56e-05	0.00029	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—malignant glioma	4.54e-05	0.000289	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BAD—malignant glioma	4.51e-05	0.000287	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH1—malignant glioma	4.47e-05	0.000284	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—malignant glioma	4.4e-05	0.00028	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TERT—malignant glioma	4.38e-05	0.000279	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CD—malignant glioma	4.38e-05	0.000279	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTT1—malignant glioma	4.38e-05	0.000279	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CD80—malignant glioma	4.38e-05	0.000279	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CG—malignant glioma	4.37e-05	0.000278	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APC—malignant glioma	4.37e-05	0.000278	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—malignant glioma	4.34e-05	0.000276	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGF—malignant glioma	4.32e-05	0.000275	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTPN11—malignant glioma	4.29e-05	0.000273	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—KRAS—malignant glioma	4.29e-05	0.000273	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PDGFB—malignant glioma	4.28e-05	0.000272	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGFR1—malignant glioma	4.26e-05	0.000271	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.25e-05	0.00027	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGF2—malignant glioma	4.2e-05	0.000267	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—malignant glioma	4.19e-05	0.000267	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CAV1—malignant glioma	4.17e-05	0.000265	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BRAF—malignant glioma	4.11e-05	0.000261	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS1—malignant glioma	4.11e-05	0.000261	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—IDH2—malignant glioma	4.09e-05	0.00026	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CAV1—malignant glioma	4.06e-05	0.000258	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTP1—malignant glioma	4.03e-05	0.000256	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—malignant glioma	4.01e-05	0.000255	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT2—malignant glioma	4e-05	0.000254	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—malignant glioma	3.98e-05	0.000253	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	3.94e-05	0.000251	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MDM2—malignant glioma	3.93e-05	0.00025	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAT—malignant glioma	3.92e-05	0.000249	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAF1—malignant glioma	3.91e-05	0.000249	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB2—malignant glioma	3.87e-05	0.000246	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—F2—malignant glioma	3.86e-05	0.000246	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FN1—malignant glioma	3.86e-05	0.000246	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.85e-05	0.000245	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	3.84e-05	0.000244	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	3.82e-05	0.000243	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—BCHE—malignant glioma	3.82e-05	0.000243	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BAD—malignant glioma	3.81e-05	0.000243	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	3.81e-05	0.000242	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—malignant glioma	3.8e-05	0.000242	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	3.78e-05	0.00024	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC5A5—malignant glioma	3.77e-05	0.00024	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—KRAS—malignant glioma	3.76e-05	0.000239	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CD80—malignant glioma	3.7e-05	0.000235	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NCOR1—malignant glioma	3.7e-05	0.000235	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APC—malignant glioma	3.69e-05	0.000235	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	3.69e-05	0.000235	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGF2—malignant glioma	3.68e-05	0.000234	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—malignant glioma	3.67e-05	0.000233	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—malignant glioma	3.67e-05	0.000233	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGF—malignant glioma	3.65e-05	0.000232	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTPN11—malignant glioma	3.63e-05	0.000231	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	3.55e-05	0.000226	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—IDH1—malignant glioma	3.52e-05	0.000224	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—malignant glioma	3.51e-05	0.000223	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—malignant glioma	3.51e-05	0.000223	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.47e-05	0.000221	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—malignant glioma	3.47e-05	0.000221	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	3.46e-05	0.00022	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MDM2—malignant glioma	3.44e-05	0.000219	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RAF1—malignant glioma	3.43e-05	0.000218	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SPHK1—malignant glioma	3.41e-05	0.000217	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB2—malignant glioma	3.39e-05	0.000216	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT2—malignant glioma	3.38e-05	0.000215	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—malignant glioma	3.37e-05	0.000214	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	3.35e-05	0.000213	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CD—malignant glioma	3.34e-05	0.000212	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.34e-05	0.000212	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—malignant glioma	3.32e-05	0.000211	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTEN—malignant glioma	3.3e-05	0.00021	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	3.25e-05	0.000207	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—malignant glioma	3.22e-05	0.000205	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—malignant glioma	3.22e-05	0.000205	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	3.22e-05	0.000205	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—KRAS—malignant glioma	3.18e-05	0.000202	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGF2—malignant glioma	3.11e-05	0.000198	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	3.11e-05	0.000198	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—malignant glioma	3.08e-05	0.000196	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—malignant glioma	3.08e-05	0.000196	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—malignant glioma	3.04e-05	0.000193	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAV1—malignant glioma	3.02e-05	0.000192	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—malignant glioma	2.98e-05	0.00019	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAT—malignant glioma	2.96e-05	0.000188	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—malignant glioma	2.95e-05	0.000188	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	2.92e-05	0.000186	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.91e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—malignant glioma	2.91e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MDM2—malignant glioma	2.91e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAF1—malignant glioma	2.9e-05	0.000184	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTEN—malignant glioma	2.89e-05	0.000184	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—malignant glioma	2.88e-05	0.000183	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB2—malignant glioma	2.87e-05	0.000182	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	2.83e-05	0.00018	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—malignant glioma	2.82e-05	0.00018	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NCOR1—malignant glioma	2.79e-05	0.000178	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.75e-05	0.000175	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—malignant glioma	2.74e-05	0.000174	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—malignant glioma	2.72e-05	0.000173	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTT1—malignant glioma	2.7e-05	0.000172	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—malignant glioma	2.68e-05	0.000171	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—malignant glioma	2.65e-05	0.000169	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	2.63e-05	0.000167	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—malignant glioma	2.61e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—malignant glioma	2.6e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—malignant glioma	2.6e-05	0.000165	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—malignant glioma	2.59e-05	0.000165	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KRAS—malignant glioma	2.53e-05	0.000161	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS1—malignant glioma	2.53e-05	0.000161	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTEN—malignant glioma	2.52e-05	0.00016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—malignant glioma	2.46e-05	0.000156	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTEN—malignant glioma	2.45e-05	0.000156	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.41e-05	0.000154	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—malignant glioma	2.41e-05	0.000153	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—malignant glioma	2.39e-05	0.000152	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—malignant glioma	2.35e-05	0.00015	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BCHE—malignant glioma	2.35e-05	0.00015	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	2.33e-05	0.000148	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.32e-05	0.000148	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAV1—malignant glioma	2.28e-05	0.000145	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—malignant glioma	2.25e-05	0.000143	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KRAS—malignant glioma	2.22e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—malignant glioma	2.21e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—malignant glioma	2.19e-05	0.000139	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.1e-05	0.000134	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—malignant glioma	2.09e-05	0.000133	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—malignant glioma	2.07e-05	0.000132	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	2.04e-05	0.00013	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—malignant glioma	2.03e-05	0.000129	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—malignant glioma	2e-05	0.000127	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—malignant glioma	1.99e-05	0.000126	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—malignant glioma	1.98e-05	0.000126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—malignant glioma	1.9e-05	0.000121	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KRAS—malignant glioma	1.88e-05	0.000119	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—malignant glioma	1.87e-05	0.000119	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CD—malignant glioma	1.82e-05	0.000116	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAT—malignant glioma	1.82e-05	0.000116	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTEN—malignant glioma	1.82e-05	0.000116	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.77e-05	0.000113	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	1.73e-05	0.00011	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOR1—malignant glioma	1.72e-05	0.000109	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—malignant glioma	1.67e-05	0.000106	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—malignant glioma	1.67e-05	0.000106	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CB—malignant glioma	1.59e-05	0.000101	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—malignant glioma	1.57e-05	0.0001	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—malignant glioma	1.45e-05	9.22e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—malignant glioma	1.41e-05	8.97e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAV1—malignant glioma	1.4e-05	8.92e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTEN—malignant glioma	1.37e-05	8.73e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.28e-05	8.16e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.28e-05	8.12e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—malignant glioma	1.23e-05	7.84e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.12e-05	7.14e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—malignant glioma	1.05e-05	6.67e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.78e-06	6.22e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—malignant glioma	9.69e-06	6.17e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—malignant glioma	9.68e-06	6.16e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTEN—malignant glioma	8.45e-06	5.38e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—malignant glioma	7.91e-06	5.03e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.96e-06	3.79e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—malignant glioma	4.87e-06	3.1e-05	CbGpPWpGaD
